DEXCOM INC
For the period ended Dec 31, 2025. Filed Feb 12, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 12, 2026
DXCM$79.92-1.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Stockholders’ Equity
DexCom, Inc.
Consolidated Statements of Stockholders’ Equity
| Accumulated Other Comprehensive Income (Loss) | ||||||||
|---|---|---|---|---|---|---|---|---|
| Common Stock · AdditionalPaid-InCapital · Translation Adjustments and Other · Net Unrealized Gain (Loss) on Marketable Securities · Retained Earnings · Treasury Stock · TotalStockholders’Equity | ||||||||
| (In millions) · Shares · Amount | ||||||||
| Balance at December 31, 2022 | 386.3 | $0.4 | $2,258.1 | $(7.8) | $(3.8) | $479.9 | $(595.0) | $2,131.8 |
| Issuance of common stock under equity incentive plans | 1.4 | — | — | — | — | — | — | — |
| Issuance of common stock for Employee Stock Purchase Plan | 0.3 | — | 26.6 | — | — | — | — | 26.6 |
| Issuance of common stock in connection with achievement of sales-based milestone, net of issuance costs | 3.7 | — | (323.4) | — | — | — | 323.2 | (0.2) |
| Purchases of treasury stock, including excise tax | (6.3) | — | (0.2) | — | — | — | (689.0) | (689.2) |
| Tax benefit related to Senior Convertible Notes | — | — | (4.4) | — | — | — | — | (4.4) |
| Conversions of 2023 Notes | 12.2 | — | (13.1) | — | — | — | — | (13.1) |
| Benefit of note hedge upon conversions of 2023 Notes | (12.2) | — | 1,496.5 | — | — | — | (1,490.3) | 6.2 |
| Purchase of capped call transactions, net of tax | — | — | (76.3) | — | — | — | — | (76.3) |
| Share-based compensation expense | — | — | 150.8 | — | — | — | — | 150.8 |
| Net income | — | — | — | — | — | 541.5 | — | 541.5 |
| Other comprehensive income, net of tax | — | — | — | (9.2) | 4.1 | — | — | (5.1) |
| Balance at December 31, 2023 | 385.4 | 0.4 | 3,514.6 | (17.0) | 0.3 | 1,021.4 | (2,451.1) | 2,068.6 |
| Issuance of common stock under equity incentive plans | 1.3 | — | — | — | — | — | — | — |
| Issuance of common stock for Employee Stock Purchase Plan | 0.4 | — | 28.2 | — | — | — | — | 28.2 |
| Issuance of common stock in connection with achievement of sales-based milestone, net of issuance costs | 1.5 | — | (188.1) | — | — | — | 188.1 | — |
| Purchases of treasury stock, including excise tax | (10.4) | — | — | — | — | — | (749.5) | (749.5) |
| Exercise and settlement of warrants | 12.5 | — | (1,431.3) | — | — | — | 1,431.3 | — |
| Share-based compensation expense | — | — | 170.4 | — | — | — | — | 170.4 |
| Net income | — | — | — | — | — | 576.2 | — | 576.2 |
| Other comprehensive income, net of tax | — | — | — | 8.6 | 0.1 | — | — | 8.7 |
| Balance at December 31, 2024 | 390.7 | 0.4 | 2,093.8 | (8.4) | 0.4 | 1,597.6 | (1,581.2) | 2,102.6 |
| Issuance of common stock under equity incentive plans | 1.4 | — | — | — | — | — | — | — |
| Issuance of common stock for Employee Stock Purchase Plan | 0.4 | — | 28.1 | — | — | — | — | 28.1 |
| Purchases of treasury stock, including excise tax | (7.7) | — | — | — | — | — | (503.6) | (503.6) |
| Share-based compensation expense | — | — | 159.6 | — | — | — | — | 159.6 |
| Net income | — | — | — | — | — | 836.3 | — | 836.3 |
| Other comprehensive income, net of tax | — | — | — | 122.2 | 0.8 | — | — | 123.0 |
| Balance at December 31, 2025 | 384.8 | $0.4 | $2,281.5 | $113.8 | $1.2 | $2,433.9 | $(2,084.8) | $2,746.0 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.